Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;73(8):1567-1569.
doi: 10.1002/art.41712. Epub 2021 Jun 20.

Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et al

Stanley B Cohen  1 , Theodore Mellors  2 , Martin J Bergman  3
Affiliations
Comment

Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et al

Stanley B Cohen et al. Arthritis Rheumatol. 2021 Aug.
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Tao W, Radstake TRDJ, Pandit A. Tao W, et al. Arthritis Rheumatol. 2021 Aug;73(8):1569-1570. doi: 10.1002/art.41711. Epub 2021 Jun 17. Arthritis Rheumatol. 2021. PMID: 33682325 No abstract available.

Comment on

References

    1. Tao W, Concepcion AN, Vianen M, Marijnissen AC, Lafeber FP, Radstake TR, et al. Multiomics and machine learning accurately predict clinical response to adalimumab and etanercept therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 2021;73:212-22.
    1. Mellors T, Withers JB, Ameli A, Jones A, Wang M, Zhang L, et al. Clinical validation of a blood-based predictive test for stratification of response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients. Netw Syst Med 2020;3:91-104.
    1. Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP. Should improvements in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum 1998;41: 1564-70.
    1. Bergman MJ, Kivitz AJ, Pappas DA, Kremer JM, Zhang L, Jeter A, et al. Clinical utility and cost savings in predicting inadequate response to anti-TNF therapies in rheumatoid arthritis. Rheumatol Ther 2020;7:775-92.
    1. Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, et al. A proteome-scale map of the human interactome network. Cell 2014;159:1212-26.

LinkOut - more resources